Fulcrum Therapeutics (FULC) Shares Issued (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Shares Issued data on file, last reported at $13.9 million in Q1 2026.

• On a quarterly basis, Shares Issued rose 15.99% year-over-year to $13.9 million in Q1 2026; TTM through Mar 2026 was $13.9 million, a 15.99% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 24.49% from the prior year.
• Shares Issued for Q1 2026 stood at $13.9 million, up from $11.6 million in the prior quarter.
• Over the last five years, Shares Issued for FULC reached as high as $13.9 million in Q1 2026 and fell as low as $1.7 million in Q1 2022.
• Historically, Shares Issued has averaged $8.0 million across 5 years, with a median of $10.0 million in 2023.
• Across the five-year window, Shares Issued sank 60.34% in 2022 and jumped 466.14% in 2023, its largest moves.
• Year by year, Shares Issued stood at $6.5 million in 2022, then jumped by 53.32% to $10.0 million in 2023, then declined by 6.19% to $9.4 million in 2024, then grew by 24.49% to $11.6 million in 2025, then grew by 19.62% to $13.9 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $13.9 million in Q1 2026, $11.6 million in Q4 2025, and $11.9 million in Q3 2025.